Frankfurt
03.12.24
09:16 Uhr
0,018 Euro
0,000
0,00 %
0,00 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.11. | IN BRIEF: Polarean Imaging gets FDA approval for MRI chest coil | 4 | Alliance News | ||
| 21.11. | Polarean's Xenoview 3T gets new FDA clearance | 1 | Sharecast | ||
| 21.11. | Polarean: FDA clears XENOVIEW 3T Chest Coil in GE HealthCare MRI Systems | 5 | GlobeNewswire (USA) | ||
| 21.11. | Polarean Imaging PLC - FDA clears Chest Coil in GE HealthCare MRI Systems | 2 | RNS | ||
| POLAREAN IMAGING Aktie jetzt für 0€ handeln | |||||
| 25.09. | Polarean Imaging PLC - Virtual investor day | 1 | RNS | ||
| 04.09. | Polarean Imaging PLC - Half-year Report | 1 | RNS | ||
| 03.09. | Polarean: Appointment of Alan Huang, PhD, as Vice President of Sales | 1 | GlobeNewswire (USA) | ||
| 03.09. | Polarean Imaging PLC - Appointment of Vice President of Sales | - | RNS | ||
| 28.08. | IN BRIEF: Polarean adds "pulmonary expertise" with new medical chief | 1 | Alliance News | ||
| 28.08. | Polarean Imaging plc: Appointment of Chase Hall, M.D., as Chief Medical Advisor | 183 | GlobeNewswire (Europe) | DURHAM, NC and LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging ("MRI") of the lungs, announces... ► Artikel lesen | |
| 28.08. | Polarean appoints Xenon MRI specialist as chief medical advisor | 1 | Sharecast | ||
| 28.08. | Polarean Imaging PLC - Appointment of Chief Medical Advisor | - | RNS | ||
| 21.08. | Polarean Imaging PLC - Notice of Results | 1 | RNS | ||
| 15.08. | Polarean Imaging retains co-founder on consultant basis | 1 | Sharecast | ||
| 15.08. | Polarean Imaging PLC - Appointment of Bastiaan Driehuys as consultant | - | RNS | ||
| 01.08. | Polarean Imaging PLC - FDA submission to expand minimum age for XENOVIEW | - | RNS | ||
| 31.07. | Polarean Imaging PLC - New Xenon MRI System trade-in agreement | - | RNS | ||
| 29.07. | Polarean Imaging PLC - Repricing of Options and Grant of Options | - | RNS | ||
| 24.07. | Polarean Imaging PLC - Result of AGM | - | RNS | ||
| 19.07. | Polarean Imaging PLC - Xenon MRI System trade-in agreement | 1 | RNS |
Seite:
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 81,52 | -1,09 % | Kestra Investment Management LLC Purchases New Holdings in Medtronic plc (NYSE:MDT) | ||
| HCA HEALTHCARE | 313,40 | +0,42 % | How Is HCA Healthcare's Stock Performance Compared to Healthcare Provider Stocks? | ||
| LANTHEUS | 83,30 | -2,39 % | Lantheus Holdings - LNTH: Was war das? Mega-Absturz nach den Quartalszahlen! | Jetzt Bärenflagge bei der Lantheus-Aktie (LNTH)! Leerverkauf starten? Durchwachsene Zahlen oder Trump-/Kennedy-Effekt? Lantheus Hodings (LNTH) - ISIN US5165441032 Rückblick: Heftige Volatilität mit... ► Artikel lesen | |
| AMEDISYS | 85,50 | 0,00 % | Amedisys falls as divestiture buyer in sale to UnitedHealth has legal judgement against it | ||
| ENVISTA | 21,000 | -1,87 % | Envista Holdings Corporation: Envista Reports Third Quarter 2024 Results | BREA, Calif., Oct. 30, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the third quarter of 2024.
For the quarter... ► Artikel lesen | |
| CAREDX | 23,400 | -4,26 % | Higher-Than-Anticipated Reimbursement Rates Lifted CareDx (CDNA) | ||
| SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports Fiscal First Quarter 2025 Results | Reports 60% Increase in ARR to $17.6 Million, Positive Net Income and Cash Flow, Adjusted EBITDA of $1.3 Million HENDERSON, Nev., Nov. 14, 2024 /PRNewswire/ -- Research Solutions, Inc.... ► Artikel lesen | |
| GT BIOPHARMA | 2,780 | 0,00 % | GT Biopharma, Inc.: GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia | GTB-3650 Phase 1 trial initiation expected in H2 2024; initial clinical data expected in H1 2025GTB-5550 TriKE® IND submission for treatment of B7H3 positive solid tumors expected in Q1 2025GTB-5550... ► Artikel lesen | |
| CARMAT | 1,098 | -4,69 % | Successful first "Aeson European User Meeting", marking an important step in the deployment of CARMAT's artificial heart | More than 100 healthcare professionals from 41 hospitals and 10 countries rallied to share their experiences of the Aeson® artificial heart All hospitals taking part in the event confirmed... ► Artikel lesen | |
| CHEMOMETEC | 65,35 | +0,77 % | Chemometec A/S: Upgrade of revenue and operating profit guidance | ANNOUNCEMENT NO. 285 3 December 2024 Upgrade of revenue and operating profit guidance ChemoMetec sustained its positive performance in the second quarter of 2024/25 with better-than-expected sales... ► Artikel lesen | |
| HAMILTON THORNE | 1,490 | -3,25 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.12.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 02.12.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.12.2024ISIN NameCA81012R1064 SCOTTIE... ► Artikel lesen | |
| DEVYSER DIAGNOSTICS | 11,200 | -1,75 % | Devyser Diagnostics AB: Devyser Diagnostics AB publishes quarterly report for the period July to September 2024 | "It is very gratifying to see the impact that we are having in the field of diagnostics. I have just returned from the ASHI event, a major transplantation conference in the US, and it is clear that... ► Artikel lesen | |
| ARRAIL GROUP | 0,338 | +1,20 % | ARRAIL GROUP (06639): VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING IN THE COMPANY BY THE FOUNDER, CHAIRMAN AND CHIEF EXECUTIVE OFFICER | ||
| FRESENIUS | 33,870 | +1,38 % | Fresenius SE Aktie: Alles sieht bestens aus! | Die Fresenius SE-Aktie verzeichnete heute einen erfreulichen Handelstag an der XETRA-Börse. Der Anteilsschein legte im Tagesverlauf um 0,7 Prozent zu und erreichte zwischenzeitlich einen Höchststand... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 44,430 | +3,11 % | Sartorius, Fresenius Medical Care, Hochtief: Da ist noch ordentlich Luft nach oben! | Sartorius, Fresenius Medical Care und Hochtief sind laufende RuMaS Express-Service-Empfehlungen und haben mit dem vorgeschlagenen Hebel-Zertifikat schöne Gewinne gemacht. Nur mit etwas mehr Risiko kann... ► Artikel lesen |
POLAREAN IMAGING PLC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,018 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu POLAREAN IMAGING PLC finden Sie auf Wallstreet Online.
